Further investigation into the changes in PDGFRβ signaling, especially p-ERK/RUNX2, cross-sectionally in brain samples from patients with PFBC and elderly individuals is crucial for a better understanding of species differences and regional differences in brain calcification and the development of targeted treatment strategies for the disorder. Here, RUNX2 is linked to bilateral striopallidodentate calcinosis.